Abstract
In some cases a combination of several malignant tumours in one person can be observed. In such case it is the multifocal primary tumour (MPT). The tumours combination in genitourinary system is rare phenomenon, including a rare combination of prostate and urinary bladder cancers. These pathologies can be caused by both the endogenous factors - age, gender, heredity, inflammatory and proliferative processes, abnormal inclusions (calculi and amyloids) and exogenous factors, among which the leading cause is the environmental pollution (heavy metals salts and others), bad habits, occupational hazards, oncogenic viruses and ionizing radiation. A 76 - year- old male patient, Ukrainian, was hospitalized at urology department with complaints on pollakiuria, frequent urinary retention, haematuria appeared about 1 month before. After examination of patient the preliminary diagnosis was made: «Urinary bladder cancer, acute urinary retention, macrohematuria and posthemorrhagic anemia». Based on the histological and immunohistochemical examinations, the final diagnosis was determined: combined malignant tumours - acinar adenocarcinoma of prostate index 9 (5 + 4) accordimg to D.F. Gleason and invasive urothelial carcinoma of the urinary bladder. This clinical case demonstrates that the probability of combined oncologic cancer pathology with lesions in one system is rather high. Therefore, in order to exclude the cancer combinations, the patients with malignant tumour in the genitourinary system should undergo a complex examination.Bangladesh Journal of Medical Science Vol.16(1) 2017 p.161-165
Highlights
Urinary bladder cancer (UBC) is highly ranked among oncologic pathologies and accounts up to 3.3% of all malignant tumours
Prostate cancer (PC) is a tumour that is more common in men aged over 70 years
In most cases the prostate and urinary bladder cancers can be diagnosed by clinical, laboratory and instrumental examinations[6,7]
Summary
Urinary bladder cancer (UBC) is highly ranked among oncologic pathologies and accounts up to 3.3% of all malignant tumours. As the diagnosis and treatment methods are constantly improved, the 5-year survival of patients with prostate and urinary bladder cancers has increased. The tumours combination in genitourinary system is rare phenomenon 10, including a rare combination of prostate and urinary bladder cancers 6. Based on the histological and immunohistochemical studies, the final diagnosis was determined: combined malignant tumours - acinar adenocarcinoma of prostate index 9 (5 + 4) accordimg to D.F. Gleason and invasive urothelial carcinoma of the urinary bladder (Table 1). Medicinal postoperative treatment included the third-generation cephalosporin and fluoroquinolones antibiotics, analgesics and antiseptics
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
